Morgan Stanley arrives at Tuesday's Q2 print having recovered sharply from the mid-June consolidation that defined the last preview — yet options traders have not abandoned their defensive posture even as the stock pushes to new highs.
The price recovery is the clearest change since the July 6 report. MS closed at $222.28 on Thursday, up nearly 4% on the week and almost 6% over the past month — a full round-trip from the $212 trough and a new post-correction high, now sitting above the June 23 peak of roughly $227 cited in the prior note. That rebound has been accompanied by a wave of analyst target upgrades: BofA lifted its target to $250, UBS to $255, Goldman Sachs to $233, and Evercore ISI to $233, all within the past week. Every one of those moves was a raise, not a rating change — the Street is chasing price, not conviction. Goldman's $233 target carries a Neutral rating, and JPMorgan holds Neutral at $187, a number that looks notably conservative relative to current trading. Oppenheimer issued the lone downgrade, moving to Underperform on June 30. The consensus mean sits at $218, which the stock has now surpassed — a setup where the market is pricing in more optimism than the average analyst is willing to formally endorse.
The bull case centres on wealth management momentum, excess capital, and the technology integration story. Bears point to a sharp rise in credit provisions, tangible book value growth of just 3.2%, and the institutional securities segment's volatility — the business that will likely drive the biggest earnings day surprise in either direction. The put/call ratio at 1.45 is running above its 20-day average of 1.43, though the z-score of 0.47 marks a meaningful retreat from the two-standard-deviation reading flagged nine days ago. Options defensiveness has eased but not unwound — put demand relative to calls remains structurally elevated versus the mid-June baseline. Short interest, at just over 1% of the free float and falling for a month, tells no bearish story; borrow availability is effectively unconstrained, and cost to borrow at 0.44% is near its lowest level in weeks.
Peers have moved in different directions this week. GS tracked closely, up roughly 3.3%. STT and BNY both rose between 3.6% and 5.6%. EVR, JEF, and MC were all lower on the week — with MC off 7% — suggesting that the rally in MS and the bulge-bracket names reflects something more specific than a broad financials lift. The last two quarterly prints saw a modest one-day dip followed by a five-day gain, a pattern that reinforces the notion that near-term hedging has historically been rewarded more slowly than immediately.
Tuesday's print will test whether the wealth management division can sustain its margin premium at current revenue levels, and whether institutional trading revenues justify a stock that has now outrun most of the Street's formal price targets.
See the live data behind this article on ORTEX.
Open MS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
